Evropská unie - dánština - EMA (European Medicines Agency)

valneva austria gmbh - covid-19 vaccine (inactivated, adjuvanted, adsorbed) - covid-19 virus infection - vacciner - covid-19 vaccine (inactivated, adjuvanted) valneva is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 18 to 50 years of age.  the use of this vaccine should be in accordance with official recommendations.

Evropská unie - dánština - EMA (European Medicines Agency)

janssen-cilag international nv - fentanylhydrochlorid - smerte, postoperative - analgetika - håndtering af akutte moderat til svær post-operative smerter til brug på et hospital indstilling kun.

Evropská unie - dánština - EMA (European Medicines Agency)

incline therapeutics europe ltd - fentanylhydrochlorid - smerte, postoperative - analgetika - ionsys er indiceret til behandling af akut moderat til svær postoperativ smerte hos voksne patienter.

Dánsko - dánština - Lægemiddelstyrelsen (Danish Medicines Agency)

sandoz a/s - buprenorphinhydrochlorid - resoribletter, sublinguale - 8 mg

Dánsko - dánština - Lægemiddelstyrelsen (Danish Medicines Agency)

medical valley invest ab - atorvastatincalcium (trihydrat) - filmovertrukne tabletter - 20 mg

Dánsko - dánština - Lægemiddelstyrelsen (Danish Medicines Agency)

medical valley invest ab - atorvastatincalcium (trihydrat) - filmovertrukne tabletter - 40 mg

Dánsko - dánština - Lægemiddelstyrelsen (Danish Medicines Agency)

medical valley invest ab - atorvastatincalcium (trihydrat) - filmovertrukne tabletter - 80 mg

Dánsko - dánština - Lægemiddelstyrelsen (Danish Medicines Agency)

sanofi a/s - ambroxolhydrochlorid - sugetabletter - 20 mg

Dánsko - dánština - Ecolab

ecolab deutschland gmbh -

Evropská unie - dánština - EMA (European Medicines Agency)

bayer ag - riociguat - hypertension, lunge - antihypertensive midler til pulmonal arteriel hypertension - chronic thromboembolic pulmonary hypertension (cteph)adempas is indicated for the treatment of adult patients with who functional class (fc) ii to iii withinoperable cteph,persistent or recurrent cteph after surgical treatment,to improve exercise capacity. pulmonary arterial hypertension (pah)adultsadempas, as monotherapy or in combination with endothelin receptor antagonists, is indicated for the treatment of adult patients with pulmonary arterial hypertension (pah) with who functional class (fc) ii to iii to improve exercise capacity. effekten har været vist i en pah befolkningen, herunder aetiologies af idiopatisk eller arvelige pah eller pah, der er forbundet med bindevævssygdom. paediatricsadempas is indicated for the treatment of pah in paediatric patients aged less than 18 years of age and body weight ≥ 50 kg with who functional class (fc) ii to iii in combination with endothelin receptor antagonists.